Eris Lifesciences informs about disclosure

19 Jul 2022 Evaluate
Eris Lifesciences has informed that the Company has given a corporate guarantee in favour of Eris Therapeutics Limited ('ETL'), a Wholly Owned Subsidiary, for securing the term loan facility that it availed from Citi Bank N.A. Further, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para B (11) of Part A to the Schedule III of the Listing Regulations and circular issued by the Securities and Exchange Board of India vide no. CIR/CFD/CMD/4/2015 dated September 9, 2015, details attached.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

907.10 9.95 (1.11%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.